Opsoclonus After COVID-19 in an Infant

Pediatr Neurol. 2021 Apr:117:34. doi: 10.1016/j.pediatrneurol.2020.12.009. Epub 2021 Jan 1.

Authors

Darion L Heald¹, Irisa M Devine², Roderic L Smith², Sarah A T Holsopple³, Jessica L Arasmith³, Robert W Arnold⁴

Affiliations

¹ University of Washington School of Medicine, WWAMI, Anchorage, Alaska.
² Pediatric Neurology, Anchorage, Alaska.
³ Pediatric Specialists of Alaska, The Children's Hospital at Providence, Anchorage, Alaska.
⁴ Alaska Children's EYE & Strabismus, Anchorage, Alaska. Electronic address: eyedoc@alaska.net.

PMID: 33662888
PMCID: PMC7775259
DOI: 10.1016/j.pediatrneurol.2020.12.009

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19*
Child, Preschool
Encephalitis*
Humans
Infant
Ocular Motility Disorders*
Opsoclonus-Myoclonus Syndrome*
Receptors, N-Methyl-D-Aspartate
SARS-CoV-2

Substances

Receptors, N-Methyl-D-Aspartate